Oregon Psychedelic Therapy: Costs, Access, and Safety

Oregon psychedelic therapy is the common shorthand for a program the state itself is careful not to call therapy: a regulated, supervised psilocybin service available to any adult 21 or older, with no diagnosis, prescription, or referral required. Sessions happen at licensed service centers under a trained facilitator, cost roughly $1,000 to $3,000 out of pocket, are not covered by insurance, and — through late 2025 — have served about 16,000 clients with an adverse-event-free rate above 99%.¹²³

What the program is, and isn’t, matters before you look at cost or logistics.

What Oregon’s Program Actually Is

Voters passed Ballot Measure 109 in November 2020 with about 56% support. The law, now codified as ORS 475A, created what regulators call a “supported adult use” model. It is not recreational legalization, and it is not a medical treatment program.¹

The distinction is legal, not cosmetic. The regulations state that psilocybin services “are not a medical or clinical treatment,” and facilitators are barred from diagnosing, treating, or counseling clients for mental health conditions. The word “therapy” is specifically prohibited in this context.⁴ So while many clients arrive seeking help with anxiety, depression, or PTSD, and many facilitators bring clinical backgrounds, the transaction on paper is a supervised experience, not a course of treatment.

The Oregon Health Authority oversees the program and licenses four kinds of participants: service center operators, facilitators, manufacturers, and testing labs.⁵

How a Session Works

The program is built around three required phases.

Preparation. You complete intake paperwork, review informed consent and a Client Bill of Rights, and work with your facilitator on a safety and transportation plan. Facilitators screen against three mandatory disqualifiers: active psychosis, use of lithium within the past 30 days, or active ideation of harm to self or others. Beyond those, a facilitator can decline to serve a client for any reason.⁶

Administration. This is the only phase in which psilocybin is purchased and consumed. It happens at a licensed service center, under direct facilitator supervision, and you stay on-site for a minimum duration tied to the dose. The average dose in 2025 was about 24.47 milligrams.³ Group sessions are allowed. Facilitator-to-client ratios tighten as doses rise, ranging from one facilitator per 25 clients at doses under 5 milligrams to one per two at doses above 35 milligrams, with group sessions capped at 25 clients or the room’s occupancy.⁷

Integration. Within 72 hours of the administration session, the facilitator meets with you to discuss the experience, review your safety plan, and provide referrals for peer support or community resources.⁶

Product forms come from a single approved species, Psilocybe cubensis: whole dried mushrooms, ground homogenized fungi, extracts, and edibles, each tested by a state-accredited lab before it reaches a center.⁸

What It Costs and Whether Insurance Covers It

Oregon does not regulate pricing. Each service center and facilitator sets rates.⁶ A single session commonly runs from about $1,000 to $3,000, depending on the center, the dose, and whether you go individual or group. Group formats are cheaper, sometimes $650 to $1,200 on a sliding scale. At least one center offers microdosing packages at roughly $200 for ten sessions.⁹

Insurance almost never covers any of it. Psilocybin remains a Schedule I substance under federal law, and Oregon’s framework is explicitly non-medical, so private plans and government medical assistance programs generally exclude these costs. ORS 475A itself says nothing in the Act requires them to pay.⁵ Everything is out of pocket. If you travel from another state, you also pay your own transportation and lodging.¹⁰

Product prices have dropped since launch. The average price per psilocybin product fell from about $85 in 2023 to an estimated $50 by mid-2026, though session prices reflect facilitator time and center overhead more than the product itself.²

Who Can Use It, and Who Actually Is

Eligibility is simple: you must be 21 or older, and you must clear the facilitator’s screening. No diagnosis is required. No Oregon residency is required.

The client base skews older, wealthier, and whiter than Oregon’s general population. Median client age is 46, with about 20% over 60. Estimated average household income is roughly $153,000. Clients identifying as white or European make up 84% to 92% of participants depending on the quarter, Hispanic or Latino clients about 7%, and African American clients about 2%.² Women make up about 57%, and LGBTQ+ individuals about 27% of the annual client pool.³

Out-of-state clients are a large share. About 33% of 2025 participants came from outside Oregon, peaking at 38.5% in the third quarter, and an estimated 60% of all clients since the program’s launch have come from other states.¹¹³

The reasons clients give for seeking services cluster around general health and wellness (31%), change of perspective (28%), and expanded consciousness (27%). Mental health concerns motivate a substantial minority: 24% cite anxiety, 22% depression, and 13% PTSD.³

Where You Can Access Services

Measure 109 let cities and counties opt out by voter approval at a statewide general election. In November 2022, 137 jurisdictions did so — 24 counties and 115 towns and cities — with only a handful of proposed bans failing, including county-wide measures in Deschutes and Jackson counties. Seventeen of the bans were temporary, lasting two years. In November 2024, 16 additional cities and unincorporated Clackamas County put ban measures on the ballot.¹²¹³

As of early 2026, roughly 25 of Oregon’s 36 counties had opted out, concentrating available services in the Portland metro area, parts of the Willamette Valley, and a handful of other jurisdictions. Zoning restrictions in opted-in areas also matter — service centers cannot be located within 1,000 feet of a school.¹¹

Availability has also thinned. By early 2026, about a third of the originally licensed service centers had closed — 12 out of 35 — leaving 23 in operation. Portland’s largest center, The Sacred Mushroom, closed in December 2025.⁹² Services must be delivered in person at a licensed center; a pending federal lawsuit challenges that restriction on behalf of disabled and terminally ill people who cannot travel to one, but as of mid-2026 the case remained active and the in-person requirement stood.¹⁴

Safety Record

The data has been favorable so far. In 2025, behavioral adverse events occurred at 2.42 per 1,000 sessions and medical adverse events at 2.79 per 1,000. Seven cases across the whole year were classified as severe — five behavioral, two medical — requiring hospital transport. The adverse-event-free rate stayed above 99%.³ When emergency services have been called, the reason has typically been client agitation or anxiety rather than a medical emergency.¹¹

Data collection tightened under Senate Bill 303. Since January 2025, clients in administration sessions complete a standardized data form (opt-out permitted), and results feed a public dashboard and are shared with Oregon Health and Science University for research.¹⁵

The Facilitator-Training Critique

The most persistent criticism from parts of the medical and psychiatric community concerns who is running sessions. The Oregon Psychiatric Physicians Association and the American Psychiatric Association opposed Measure 109, citing the absence of Phase III clinical trials and objecting to non-physicians administering a federally controlled substance.¹⁶

Facilitators need a high school diploma or equivalent, roughly 120 hours of training through an OPS-approved curriculum, and a passing score of at least 75% on a state regulations exam. Critics point out that this is about a quarter of the training Oregon requires for a massage therapy license, and that facilitators are not required to hold any mental health or medical credential yet are responsible for screening clients and managing sessions that can produce intense psychological distress.¹⁶¹⁷ Clinical trials for psilocybin have typically excluded people with histories of psychosis, bipolar disorder, suicidality, and some cardiovascular conditions — populations Oregon’s program does not comprehensively screen out through clinical evaluation.¹⁸ One analyst described a structural contradiction: the law bars facilitators from practicing therapy while requiring non-clinicians to perform screening tasks — evaluating lithium use, self-harm history, and behavioral health — that arguably demand clinical training.¹⁹

A 2025 law is beginning to address this. HB 2387, implemented through administrative rules effective January 1, 2026, allows licensed health care and behavioral health professionals — physicians, psychologists, clinical social workers, nurses, counselors, and naturopathic doctors — to hold facilitator licenses and use their clinical expertise during preparation and integration. They still cannot provide clinical services during the administration session itself, but they can screen, assess risk, and integrate psilocybin work into broader treatment. The bill also protects providers from disciplinary action for discussing psilocybin services with patients.²⁰ If you want a clinician in the room, you can now ask specifically for a dual-licensed facilitator.

Options If Cost Is a Barrier

Two paths exist for clients who cannot pay the standard rate.

The Sheri Eckert Foundation runs a Psilocybin Access Fund that pays grants — averaging about $1,500 per person — directly to licensed facilitators or service centers. It prioritizes people from underserved communities facing barriers of geography, race, income, or disability. The fund has raised over $670,000 and served more than 100 people, though it maintains a waitlist in the hundreds, and as of mid-2026 its capacity to issue new grants was severely constrained by fundraising challenges.²¹²² The foundation’s executive director has described the current model as reliant on “altruistic millionaires and billionaires” and philanthropic grants, calling it unsustainable for long-term equity.

A separate research study at the National University of Natural Medicine, run in collaboration with the Sheri Eckert Foundation, is examining group psilocybin sessions for low-income adults with depression. It is open to Oregon residents 21 and older earning at or below 200% of the federal poverty line, at no cost to participants.²³

If You Live in a Different State

You can travel to Oregon; a large share of clients do, and no residency requirement applies. Two other states have their own programs, structured differently.

Colorado voters approved Proposition 122 in 2022. Its framework is broader in several ways: personal cultivation and home use by adults 21 and older are permitted, sharing for counseling or spiritual purposes is allowed, dual licensure for health care providers was built in from the start, and licensing fees run about 20% lower than Oregon’s. Regulatory authority is split between the Department of Revenue for businesses and the Department of Regulatory Agencies for facilitators.²⁴¹¹

New Mexico chose a strictly medical route. Governor Michelle Lujan Grisham signed the Medical Psilocybin Act (SB 219) in April 2025, limiting the program to patients with specific diagnoses: major treatment-resistant depression, PTSD, substance use disorders, and end-of-life care. The state appropriated $2 million for program administration, $1 million for a treatment equity fund covering low-income and rural patients, and $1 million for research. The Department of Health is targeting a launch by the end of 2026, with full implementation required by December 31, 2027.²⁵²⁶

Psilocybin remains a Schedule I substance under the federal Controlled Substances Act, so state legality does not shield you outside the state where you receive services. Bringing psilocybin products home is not authorized. Oregon’s program operates without a federal accommodation, in the same gray zone that characterized early state-legal cannabis.¹⁶

1
Oregon Health Authority. Oregon Psilocybin Services
2
Psychedelic Alpha. The Oregon Psilocybin Services Tracker
3
Frontiers in Psychiatry. Oregon Psilocybin Services Program Data
4
Petrie-Flom Center, Harvard Law School. Ethical Issues Within Oregon’s Measure 109
5
Oregon State Legislature. ORS Chapter 475A
6
Oregon Health Authority. Access Psilocybin Services
7
Oregon Secretary of State. OAR 333-333-5230
8
Oregon Health Authority. Manufacturer License Fact Sheet
9
The Guardian. Oregon Psychedelic Mushrooms
10
Washington State Standard. Oregon’s Legal Psilocybin Clinics Draw Hundreds, Mostly From Out of State
11
OPB. Oregon Licensed Psilocybin
12
The Oregonian. 137 Oregon Towns and Counties Vote to Opt Out of Psilocybin Services
13
Oregon Capital Chronicle. Oregon Local Ballot Measures Seek Voter Input on Psilocybin Mushrooms
14
Marijuana Moment. Lawsuit Says Oregon’s Psilocybin Law Illegally Discriminates Against Homebound Patients
15
Oregon Health Authority. SB 303 and Data Collection
16
Journal of the American Academy of Psychiatry and the Law. Oregon Psilocybin Services
17
Oregon Health Authority. Facilitator License Application Guide
18
National Library of Medicine. Criticisms of Oregon Psilocybin Program
19
BrainFutures. Analysis of Oregon Draft Regulations
20
KLCC. Oregon Bill Would Let Some Therapists, Doctors Oversee Clients’ Psilocybin Therapy
21
OPB. New Data Shows Psilocybin Therapy Clients Wealthier
22
Sheri Eckert Foundation. Psilocybin Access Fund
23
National University of Natural Medicine. Low-Income Group Psilocybin Assisted Therapy for Depression
24
Colorado Department of Natural Medicine. Natural Medicine Frequently Asked Questions
25
New Mexico Department of Health. Medical Psilocybin Program
26
Source New Mexico. Treatment Equity Fund Expected to Widen Psilocybin Program Access